Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
288 GBX | +1.77% | 0.00% | +1.77% |
Jun. 07 | Hutchmed (China) begins trial of menin inhibitor HMPL-506 | AN |
Jun. 07 | Hutchmed Begins Phase 1 Trial of Potential Treatment for Acute Myeloid Leukemia | MT |
Financials (USD)
Sales 2024 * | 691M | Sales 2025 * | 849M | Capitalization | 3.13B |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | - | EV / Sales 2024 * | 4.16 x |
Net cash position 2024 * | 256M | Net cash position 2025 * | 383M | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
-28.9
x | P/E ratio 2025 * |
262
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.15% |
Latest transcript on HUTCHMED (China) Limited
1 day | +1.77% | ||
Current month | -2.37% | ||
1 month | -18.18% | ||
3 months | +22.55% | ||
6 months | -2.21% | ||
Current year | +1.77% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
CHM | Chairman | 70 | 16-07-31 |
Edith Shih
BRD | Director/Board Member | 71 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 288 | +1.77% | 66,197 |
24-06-07 | 283 | -2.41% | 34,721 |
24-06-06 | 290 | -0.34% | 98,576 |
24-06-05 | 291 | -2.02% | 7,791 |
24-06-04 | 297 | +3.12% | 45,201 |
Delayed Quote London S.E., June 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.77% | 3.07B | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- HCM Stock